ANTICANCER EFFECTS OF COUMARIN COMPOUNDS OSTHOLE AND IMPERATORIN, ALONE AND IN COMBINATION WITH 5-FLUOROURACIL IN COLON CARCINOMA CELLS

被引:2
|
作者
Arslan, Ayse Kubra Karaboga [1 ]
Uzunhisarcikli, Ebru [1 ]
Okcesiz, Aysun [2 ]
Eken, Ayse [2 ]
Yerer, Mukerrem Betul [1 ]
机构
[1] Erciyes Univ, Pharm Fac, Dept Pharmacol, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Pharm Fac, Dept Pharmaceut Toxicol, TR-38039 Kayseri, Turkey
来源
ACTA POLONIAE PHARMACEUTICA | 2021年 / 78卷 / 02期
关键词
osthole; imperatorin; 5-fluorouracil; colo; 205; cytotoxicity; xCELLigence; ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; ANGELICA-DAHURICA; CYCLE ARREST; SUPPRESSES PROLIFERATION; MESENCHYMAL TRANSITION; ADENOCARCINOMA CELLS; SIGNALING PATHWAY; CNIDIUM-MONNIERI; IN-VITRO;
D O I
10.32383/appdr/135086
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Colon cancer is one of the causes of cancer-related mortality. Therefore, more efficient therapy strategies are required. There is an increasing interest in natural products due to the potential cytotoxic activity in various cancer cell lines. Osthole and imperatorin are major active coumarins found in a variety of plants. The present study aimed to assess the cytotoxic effects of two natural coumarins, osthole, and imperatorin, administered separately and combined with 5-fluorouracil (5-FU) in human colon carcinoma cells and to identify the action of a mechanism. Real-time cell analysis with the xCELLigence System was used to screen for appropriate concentrations of osthole, imperatorin, 5-FU, and API-1 with cytotoxic or cytostatic potential and to monitor cell proliferation and viability in CoLo 205 cells continuously. Furthermore, the effects of the compounds on p38MAPK-alpha levels and the expression of Akt mRNA were evaluated. As a result, osthole showed considerable antiproliferative activity in CoLo 205 cells and increased the efficacy of 5-FU by accelerating the cytotoxic effect. Osthole was found to be as effective as protein kinase inhibitor API-1. Osthole, osthole+5-FU, and imperatorin treatments were significantly able to increase the ratio of phospho-p38MAPK-alpha/p38MAPK-alpha. It was demonstrated that osthole, 5-FU, and API-I+5-FU were significantly suppressed the Akt mRNA expression as positive control API-1. The findings indicate that osthole may be a promising anti-cancer agent in the treatment of colon cancer and may increase the efficacy of 5-FU and, therefore, may reduce common side effects of traditional chemotherapy in colon cancer with 5-FU.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [41] Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines
    van der Wilt, CL
    Kuiper, CM
    Peters, GJ
    ONCOLOGY RESEARCH, 1999, 11 (08) : 383 - 391
  • [42] Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells
    Kamran, Sareh
    Sinniah, Ajantha
    Chik, Zamri
    Alshawsh, Mohammed Abdullah
    BIOMEDICINES, 2022, 10 (03)
  • [43] TREATMENT OF WOMEN WITH DISSEMINATED OR RECURRENT ADVANCED OVARIAN-CANCER WITH MELPHALAN ALONE IN COMBINATION WITH 5-FLUOROURACIL AND DACTINOMYCIN OR WITH THE COMBINATION OF CYTOXAN, 5-FLUOROURACIL AND DACTINOMYCIN
    PARK, RC
    BLOM, J
    DISAIA, PJ
    LAGASSE, LD
    BLESSING, JA
    CANCER, 1980, 45 (10) : 2529 - 2542
  • [44] COMBINATION OF 5-FLUOROURACIL, INTERFERON, AND NIVOLUMAB IN THE TREATMENT OF FIBROLAMELLAR CARCINOMA
    Gottlieb, Sara
    Gliksberg, Ariel
    Kent, Paul
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S71 - S71
  • [45] COMBINATION OF 5-FLUOROURACIL AND RADIATION AS PRIMARY THERAPY OF CARCINOMA OF CERVIX
    GOOLSBY, CD
    DALY, JW
    SKINNER, OD
    GIBBS, CE
    OBSTETRICS AND GYNECOLOGY, 1968, 32 (05): : 674 - &
  • [46] Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
    Li, Su
    Wang, Anxun
    Jiang, Wenqi
    Guan, Zhongzhen
    BMC CANCER, 2008, 8 (1)
  • [47] A COMBINATION OF 5-FLUOROURACIL AND THYMIDINE IN ADVANCED COLORECTAL-CARCINOMA
    STERNBERG, A
    PETRELLI, NJ
    AU, J
    RUSTUM, Y
    MITTELMAN, A
    CREAVEN, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) : 218 - 222
  • [49] Pharmacokinetic characteristics and anticancer effects of 5-Fluorouracil loaded nanoparticles
    Su Li
    Anxun Wang
    Wenqi Jiang
    Zhongzhen Guan
    BMC Cancer, 8
  • [50] ORAL 5-FLUOROURACIL (5-FU) AS AN ADJUVANT TO SURGERY IN CARCINOMA OF COLON
    HARVEY, H
    BADDER, E
    DEMUTH, W
    NAHRWOLD, D
    PATTERSON, L
    RICCI, J
    SHAVER, W
    WHITE, D
    LIPTON, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 314 - 314